Finance

Beta
Senarai
Sektor ekuiti
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Buka
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • in 3 days
See details
NVO:NYSE
Novo Nordisk
USD 43.88
+3.93%
(+1.66) 1H
USD 43.91
+0.07% (+0.029)
Selepas waktu pejabat
Ditutup: 1 Mei, 4:00:04 PTG GMT-4  ·   USD
Semua simbol
SimbolPriceChange% Change
Generating top insights for NVO...
Buka
USD 43.31
High
USD 44.04
Low
USD 43.10
Mkt. cap
149.89B
Volume
26.25J
Dividend
4.11%
Quarterly dividend
USD 0.45
Ex dividend date
27 Mac 2026
P/E ratio
12.14
52-wk high
USD 81.44
52-wk low
USD 35.12
EPS
USD 3.62
Beta
0.73
Shares outstanding
3.39B
No. of employees
69K
News stories
From sources across the web
Profil
Novo Nordisk A/S ialah sebuah syarikat farmaseutikal multinasional Denmark yang beribu pejabat di Bagsværd, Denmark, dengan kemudahan pengeluaran di lapan negara, dan sekutu atau pejabat di 5 negara. Novo Nordisk dikawal oleh pemegang saham majoriti Novo Holdings A/S yang memegang kira-kira 25% sahamnya dan majoriti besar saham undiannya. Novo Nordisk mengeluarkan dan memasarkan produk dan perkhidmatan farmaseutikal khususnya ubat dan peranti penjagaan diabetis. Novo Nordisk juga terlibat dengan pengurusan hemostasis, terapi hormon pertumbuhan dan terapi penggantian hormon. Syarikat itu membuat beberapa ubat di bawah pelbagai jenama, termasuk Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight dan Victoza. Novo Nordisk mempekerjakan lebih daripada 45,000 orang di seluruh dunia, dan memasarkan produknya di 180 negara. Perbadanan itu diwujudkan pada tahun 1989 melalui penggabungan dua syarikat Denmark yang bermula sejak tahun 1920-an. Logo Novo Nordisk ialah lembu jantan Apis, salah satu haiwan suci Mesir purba. Novo Nordisk ialah ahli penuh Persekutuan Industri dan Persatuan Farmaseutikal Eropah. Wikipedia
About Novo Nordisk
CEOMaziar Mike Doustdar
Employees69.2K
Founded21 Dis 1923
HeadquartersBagsværd, Wilayah Hovedstaden, Denmark
Sector-
Websitenovonordisk.com
Next call dalam 3 hari
Rab, 6 Mei, 7:00 PG
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (5.46 est.)DKK
Revenue / Estimate
-/ (71.78B est.)DKK
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Mac 2025
Jun 2025
Sep 2025
Dis 2025
Revenue
78.09B
76.86B
74.98B
79.14B
Cost of goods sold
12.89B
12.85B
14.47B
14.17B
Cost of revenue
12.89B
12.85B
14.47B
14.17B
Research and development expenses
10.31B
11.69B
11.49B
12.67B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.11B
18.85B
15.76B
17.14B
Operating expense
26.41B
30.56B
27.25B
29.73B
Total operating expenses
39.30B
43.41B
41.72B
43.90B
Operating income
38.79B
33.45B
33.25B
35.24B
Other non operating income
-
-
1.53B
-241.00J
EBT including unusual items
37.03B
33.80B
25.52B
34.18B
EBT excluding unusual items
37.03B
33.80B
35.09B
37.62B
Income tax expense
8.00B
7.30B
5.51B
7.29B
Effective tax rate
21.60%
21.60%
21.60%
21.34%
Other operating expenses
-14.00J
23.00J
-
-81.00J
Net income
29.03B
26.50B
20.01B
26.89B
Net profit margin
37.18%
34.48%
26.68%
33.98%
Earnings per share
6.53
5.96
4.50
6.04
Interest and investment income
3.42B
5.31B
307.00J
4.41B
Interest expense
-3.86B
-4.96B
-
-4.97B
Net interest expenses
-433.00J
356.00J
307.00J
-560.00J
Depreciation and amortization charges
-
-
-
-
EBITDA
42.62B
37.65B
36.49B
36.66B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer